​
​

Gain Therapeutics (GANX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Gain Therapeutics Revenue Highlights

Latest Revenue (Y)

$55.18K

0

Gain Therapeutics Revenue by Period

Gain Therapeutics Revenue by Year

DateRevenueChange
2023-12-31$55.18K-60.62%
2022-12-31$140.11K-15.08%
2021-12-31$164.99K471.29%
2020-12-31$28.88K-30.07%
2019-12-31$41.30K100.40%
2018-12-31$20.61K-

Gain Therapeutics generated $55.18K in revenue during NA 2023, up -60.62% compared to the previous quarter, and up 267.75% compared to the same period a year ago.

Gain Therapeutics Revenue by Quarter

DateRevenueChange
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$64.80K100.00%
2023-09-30-100.00%
2023-06-30--100.00%
2023-03-31$55.18K-60.62%
2022-12-31$140.11K100.00%
2022-09-30--100.00%
2022-06-30$95.10K111.31%
2022-03-31$45.01K23.84%
2021-12-31$36.34K32.90%
2021-09-30$27.34K-69.33%
2021-06-30$89.17K1592.41%
2021-03-31$5.27K-42.35%
2020-12-31$9.14K36.48%
2020-09-30$6.70K5.07%
2020-06-30$6.37K-4.50%
2020-03-31$6.67K100.00%
2019-12-31--100.00%
2019-09-30$10.32K-
2019-06-30$10.32K-
2019-03-31$10.32K100.40%
2018-09-30$5.15K-
2018-06-30$5.15K-
2018-03-31$5.15K-

Gain Therapeutics generated - in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Gain Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
NAMSNewAmsterdam Pharma Company$14.09M$2.13M
MOLNMolecular Partners$7.04M$2.74M
CUECue Biopharma$5.49M$3.34M
INBXInhibrx Biosciences$1.80M-
MNOVMediciNova$1.00M-
TFFPTFF Pharmaceuticals$733.87K$650.22K
LIFEaTyr Pharma$353.00K$235.00K
GANXGain Therapeutics$55.18K-
ANEBAnebulo Pharmaceuticals--
BIVIBioVie--
INABIN8bio--
CYTCyteir Therapeutics--
ELYMEliem Therapeutics--
CELCCelcuity--
MACKMerrimack Pharmaceuticals--
ELVNEnliven Therapeutics--
LTRNLantern Pharma--
CSBRChampions Oncology--

GANX Revenue FAQ

What is Gain Therapeutics’s yearly revenue?

Gain Therapeutics's yearly revenue for 2023 was $55.18K, representing a decrease of -60.62% compared to 2022. The company's yearly revenue for 2022 was $140.11K, representing a decrease of -15.08% compared to 2021. GANX's yearly revenue for 2021 was $164.99K, representing an increase of 471.29% compared to 2020.

What is Gain Therapeutics’s quarterly revenue?

Gain Therapeutics's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). GANX's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a -100.00% decrease year-over-year (Q1 2023).

What is Gain Therapeutics’s revenue growth rate?

Gain Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -66.56%, and for the last 5 years (2019-2023) was 33.60%.